Search
Close this search box.
Search
Close this search box.

Eko Health: Detecting Heart and Lung Diseases Earlier with AI-Enhanced Stethoscopes

Image Credits: Eko Health
By: Headliners News / June 27, 2024

Meet Eko Health, a pioneering startup in digital healthcare, has recently secured $41 million in a Series D funding round to advance its mission of revolutionizing the early detection of heart and lung diseases using AI-enhanced stethoscopes. Founded in 2013, Eko Health has transformed the traditional stethoscope into a powerful diagnostic tool by integrating artificial intelligence.

The company’s journey began with its innovative stethoscopes, which have been adopted by over 500,000 healthcare professionals globally. These devices capture detailed chest sounds and electrocardiogram (ECG) data, forming a vast dataset that powers Eko’s AI algorithms. These algorithms analyze subtle differences in heart sounds and cardiac rhythms, providing healthcare providers with enhanced diagnostic capabilities.

Connor Landgraf, CEO and founder of Eko Health, highlighted the limitations of traditional stethoscope exams, citing inconsistencies and inaccuracies in detecting heart conditions. With Eko’s AI-powered stethoscopes, healthcare professionals can now detect early signs of heart failure and heart murmurs more accurately during routine medical exams. The AI algorithms have received FDA clearance for these applications, underscoring their clinical validity and reliability.

Eko’s latest FDA clearance marks a significant milestone, allowing its AI to assist in identifying abnormal heart valves and cardiac rhythm irregularities. This capability has been shown to detect more cases of heart disease compared to traditional methods, potentially saving lives by enabling earlier interventions.

The $41 million Series D round was led by prominent investors including Artis Ventures, Highland Capital Partners, NTTVC, and Questa Capital. This funding will support Eko Health in expanding its AI capabilities to detect pulmonary conditions such as asthma and pneumonia. Additionally, it will facilitate the global distribution of Eko’s devices and software to healthcare providers outside the United States.

Vas Bailey, a partner at Artis Ventures, emphasized the practical impact of Eko’s technology in improving healthcare outcomes. Having lost his father to heart disease at a young age, Bailey views Eko’s innovations as potentially life-saving tools that could prevent similar tragedies for others.

While Eko Health stands out for integrating AI into stethoscopes, other startups like Ultromics and CardioSignal are also leveraging AI to advance cardiovascular diagnostics. These companies represent a growing trend towards integrating cutting-edge technology into traditional medical devices, aiming to enhance diagnostic accuracy and improve patient outcomes in healthcare settings worldwide.

What do you think?

3 People voted this article. 3 Upvotes - 0 Downvotes.
Please Share This